OBJECTIVE: Granulocyte colony-stimulating factor has been used to reduce the risk of sepsis in patients with traumatic brain injury. However, granulocyte colony-stimulating factor exerts potent pro- and anti-inflammatory effects that could influence secondary injury, and outcome, after traumatic brain injury. Our objective was to determine the effect of granulocyte colony-stimulating factor on histopathologic, motor, and cognitive outcome after experimental traumatic brain injury in mice. DESIGN: Experimental study. SETTING: Research laboratory at the Massachusetts General Hospital, Boston, MA. SUBJECTS: Forty-eight adult male C57Bl/6 mice. INTERVENTIONS: Mice (8 wks of age, n = 16/group) were administered granulocyte colony-stimulating factor or saline subcutaneously twice per day for 7 days after controlled cortical impact or sham injury (n = 16). Absolute neutrophil counts, motor function, Morris water maze performance, and lesion volume were determined after controlled cortical impact or sham injury. MEASUREMENTS AND MAIN RESULTS: At the time of controlled cortical impact, body weight, brain and body temperature, and systemic absolute neutrophil counts did not differ between groups. Compared with control, systemic absolute neutrophil count was increased more than ten-fold in granulocyte colony-stimulating factor-treated mice on posttrauma days 2 and 7 (p < .05, repeated-measures analysis of variance) but did not differ between groups by day 14. There were no differences between groups in tests of motor function or histopathologic outcome. However, compared with control, mice given granulocyte colony-stimulating factor had improved Morris water maze performance after controlled cortical impact (p < .05, repeated-measures analysis of variance) but not sham injury. CONCLUSIONS: The data suggest a small beneficial effect of granulocyte colony-stimulating factor on functional outcome after traumatic brain injury in adult mice but do not show differences in histopathology or motor outcome between treated and control groups.
OBJECTIVE:Granulocyte colony-stimulating factor has been used to reduce the risk of sepsis in patients with traumatic brain injury. However, granulocyte colony-stimulating factor exerts potent pro- and anti-inflammatory effects that could influence secondary injury, and outcome, after traumatic brain injury. Our objective was to determine the effect of granulocyte colony-stimulating factor on histopathologic, motor, and cognitive outcome after experimental traumatic brain injury in mice. DESIGN: Experimental study. SETTING: Research laboratory at the Massachusetts General Hospital, Boston, MA. SUBJECTS: Forty-eight adult male C57Bl/6 mice. INTERVENTIONS:Mice (8 wks of age, n = 16/group) were administered granulocyte colony-stimulating factor or saline subcutaneously twice per day for 7 days after controlled cortical impact or sham injury (n = 16). Absolute neutrophil counts, motor function, Morris water maze performance, and lesion volume were determined after controlled cortical impact or sham injury. MEASUREMENTS AND MAIN RESULTS: At the time of controlled cortical impact, body weight, brain and body temperature, and systemic absolute neutrophil counts did not differ between groups. Compared with control, systemic absolute neutrophil count was increased more than ten-fold in granulocyte colony-stimulating factor-treated mice on posttrauma days 2 and 7 (p < .05, repeated-measures analysis of variance) but did not differ between groups by day 14. There were no differences between groups in tests of motor function or histopathologic outcome. However, compared with control, mice given granulocyte colony-stimulating factor had improved Morris water maze performance after controlled cortical impact (p < .05, repeated-measures analysis of variance) but not sham injury. CONCLUSIONS: The data suggest a small beneficial effect of granulocyte colony-stimulating factor on functional outcome after traumatic brain injury in adult mice but do not show differences in histopathology or motor outcome between treated and control groups.
Authors: Sandy R Shultz; Xin L Tan; David K Wright; Shijie J Liu; Bridgette D Semple; Leigh Johnston; Nigel C Jones; Andrew D Cook; John A Hamilton; Terence J O'Brien Journal: J Neurotrauma Date: 2014-03-07 Impact factor: 5.269
Authors: Yuji Kaneko; Naoki Tajiri; Seongjin Yu; Takuro Hayashi; Christine E Stahl; Eunkyung Bae; Humberto Mestre; Nicholas Franzese; Antonio Rodrigues; Maria C Rodrigues; Hiroto Ishikawa; Kazutaka Shinozuka; Whitney Hethorn; Nathan Weinbren; Loren E Glover; Jun Tan; Anilkumar Harapanahalli Achyuta; Harry van Loveren; Paul R Sanberg; Sundaram Shivsankar; Cesar V Borlongan Journal: Cell Med Date: 2012
Authors: Sandra A Acosta; Naoki Tajiri; Kazutaka Shinozuka; Hiroto Ishikawa; Paul R Sanberg; Juan Sanchez-Ramos; Shijie Song; Yuji Kaneko; Cesar V Borlongan Journal: PLoS One Date: 2014-03-12 Impact factor: 3.240
Authors: Bi-Hung Peng; Viktoriya Borisevich; Vsevolod L Popov; Michele A Zacks; D Mark Estes; Gerald A Campbell; Slobodan Paessler Journal: Vet Microbiol Date: 2013-01-11 Impact factor: 3.293